BioSpace News Archive

Deal is part of Ginkgo’s $25 million commitment to make its biological discovery and production services available to firms working on diagnostics, treatments, and vaccines in response to COVID-19

- This adds to Abbott’s previously announced COVID-19 molecular tests: the m2000™ lab-based test and ID NOW™ rapid point-of-care test - New antibody test will run on Abbott’s ARCHITECT® i1000SR and i2000SR laboratory instruments and will expand to its new Alinity™ i system - Abbott begins shipping tomorrow and intends to distribute 4 million tests in April, ramping to 20 million in the U.S. per month in June and beyond

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the first publication utilizing the nCounter® platform and its leading gene expression panels for measuring immune response in COVID-19 research.

GE Healthcare today introduced a new software solution to support clinicians and health systems in the treatment of COVID-19 patients. The company is bringing its Mural Virtual Care Solution, which i

Aeterna Zentaris Inc. , today announced that Dr. Klaus Paulini , Chief Executive Officer of Aeterna Zentaris will present at the April 2020 Virtual Investor Summit on Thursday, April 23, 2020 at 10:00 AM ET. A live audio webcast of the presentation will be ava

Several of the world’s ventilator manufacturers announce a newly formed Ventilator Training Alliance to support frontline medical providers to access a centralized repository of ventilator training.

Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and standards-based research technology solutions announced today the appointment of Gadi Saarony as Chief Executive Officer.

FUJIFILM Corporation has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral drug “Avigan® Tablet” for treating patients with COVID-19..

Molecular Assemblies, Inc. today announced the appointment of Todd C. Peterson, Ph.D. to the company’s board of directors

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Dr. Mark Poznansky, Co-Creator of VaxCelerate, a self-assembling vaccine (SAV) platform, appeared as a guest on MSNBC’s All In with Chris Hayes last night to discuss COVID-19 vaccines and can be viewed from the following link